Trial Profile

Phase II trial assessing RE 104in Generalized Anxiety Disorder (GAD).

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 07 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Nov 2025 New trial record
30 Sep 2025 According to Reunion Neuroscience media release, company expects to initiate this RECLAIM phase 2 trial in Generalized Anxiety Disorder (GAD) in 1Q 2026
16 Sep 2025 According to the Reunion Neuroscience Media Release, the company announced the closing of its Series A financing. the Series A financing will be used to fully fund the REKINDLE Phase 2 trial in Adjustment Disorder (AjD) and to initiate the RECLAIM Phase 2 trial in Generalized Anxiety Disorder (GAD).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com